Postinfectious functional gastrointestinal disorders

Journal of Clinical Gastroenterology

Volumn 45, Issue SUPPL. 2, 2011, Pages

  Mearin, Fermín ^a  

^a CENTRO MÉDICO TEKNON   (Spain)

Author keywords

FGID; gastrointestinal; IBS; irritable; postinfectious

Indexed keywords

BACTERIAL STRAIN; CLINICAL ASSESSMENT; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE DURATION; DISEASE SEVERITY; ENTERITIS; FECES ANALYSIS; FEVER; HEALTH CARE UTILIZATION; HUMAN; HYPOCHONDRIASIS; INFLAMMATION; IRRITABLE COLON; MAST CELL; PATHOPHYSIOLOGY; POSTINFECTIOUS FUNCTIONAL GASTROINTESTINAL DISORDER; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; VOMITING;

ANIMALS; BACTERIAL INFECTIONS; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATION; IRRITABLE BOWEL SYNDROME; MAST CELLS; MICE; RISK FACTORS;

EID: 79958844022     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31821fbf58     Document Type: Review

References (34)

1. Drossman DA. The Functional Gastrointestinal Disorders. Rome III. McLean, Virginia. USA: Degnos Associates; 2006.
2. Badia X, Mearin F, Balboa A, et al. Burden of Illness in Irritable Bowel Syndrome (IBS) Comparing Rome I and Rome II Criteria. Pharmacoeconomics. 2002;20:749-758. (Pubitemid 35034443)
3. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-1479.
4. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
5. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome: a meta-analysis. Am J Gastroenterol. 2006;101:1894-1899.
6. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of postinfectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535-544. (Pubitemid 47174284)
7. Mearin F, Pérez-Oliveras M, Perelló A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005;129:98-104. (Pubitemid 41002046)
8. Ford AC, Thabane M, Collins SM, et al. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology. 2010;138:1727-1736.
9. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578-1583. (Pubitemid 36875351)
10. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245.
11. Spiller RC. Infection, immune function, and functional gut disorders. Clin Gastroenterol Hepatol. 2004;2:445-455. (Pubitemid 38698357)
12. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651-1659. (Pubitemid 37500429)
13. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permiability following acute Campylobacter enteritis and post dysenteric irritable bowel syndrome. Gut. 2000;47:804-811.
14. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523-526. (Pubitemid 36363405)
15. Khan WI, Collins SM. Gut motor function: immunological control in enteric infection and inflammation. Clin Exp Immunol. 2006;143:389-397.
16. Spiller RC. Irritable bowel syndrome: bacteria and inflammation: clinical relevance now. Curr Treat Options Gastroenterol. 2007;10:312-321. (Pubitemid 47193515)
17. Bercík P, Wang L, Verdú EF, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology. 2004;127:179-187. (Pubitemid 38962286)
18. Wheatcroft J, Wakelin D, Smith A, et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005;17:863-870. (Pubitemid 41748282)
19. Adam B, Liebregts T, Gschossmann JM, et al. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain. 2006;123:179-186. (Pubitemid 43816772)
20. Bueno L, Fioramonti J. Visceral perception: inflammatory and non-inflammatory mediators. Gut. 2002;51(suppl):19-23.
21. Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil. 2008;20(suppl):73-80. (Pubitemid 351514539)
22. Chang L, Munakata J, Mayer EA, et al. Perceptual responses in patients with inflammatory and functional bowel disease. Gut. 2000;47:497-505.
23. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913-920. (Pubitemid 46440872)
24. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol. 1997;92:954-959.
25. Balboa A, Mearin F, Badía X, et al. Impact of upper digestive symptoms in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2006;18:1271-1277. (Pubitemid 44737057)
26. Guilarte M, Santos J, de Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203-209.
27. Törnblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123:2144-2147.
28. Mearin F, Perelló A, Balboa A, et al. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol. 2009;44:1173-1185.
29. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702. (Pubitemid 38298317)
30. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400-406. (Pubitemid 29119338)
31. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136(suppl):1979-1988.
32. Thabane M, Simunovic M, Akhtar-Danesh N, et al. Development and validation of a risk score for post-infectious irritable bowel syndrome. Am J Gastroenterol. 2009;104:2267-2274.
33. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002;51:410-413.
34. Jung IS, Kim HS, Park H, et al. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol. 2009;43:534-540.